|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1994-1-19
|
|
pubmed:abstractText |
We describe 2 cases of proximal tubular defects induced by the administration of ifosfamide at a dosage of 6 g/m2/course over 2 days in children with a diagnosis of malignant mesenchymal tumors. This adverse effect could be minimized dividing dosage of the drug. However at present it is not clear if divided doses are completely safe.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
144-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7505048-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7505048-Cyclophosphamide,
pubmed-meshheading:7505048-Dactinomycin,
pubmed-meshheading:7505048-Doxorubicin,
pubmed-meshheading:7505048-Humans,
pubmed-meshheading:7505048-Ifosfamide,
pubmed-meshheading:7505048-Infant,
pubmed-meshheading:7505048-Infant, Newborn,
pubmed-meshheading:7505048-Kidney Diseases,
pubmed-meshheading:7505048-Male,
pubmed-meshheading:7505048-Rhabdomyosarcoma,
pubmed-meshheading:7505048-Urinary Bladder Neoplasms,
pubmed-meshheading:7505048-Vincristine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Ifosfamide-induced renal tubular defect.
|
|
pubmed:affiliation |
Department of Pediatric Hematology-Oncology, Social Security Hospital 12 de Octubre, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
